COP1 and GSK3β cooperate to promote c-Jun degradation and inhibit breast cancer cell tumorigenesis

Jing Shao, Yong Teng, Ravi Padia, Sungguan Hong, Hyangsoon Noh, Xiayang Xie, Jeff S. Mumm, Zheng Dong, Han Fei Ding, John Cowell, Jaejik Kim, Jiahuai Han, Shuang Huang

Research output: Contribution to journalArticle

33 Scopus citations

Abstract

High abundance of c-Jun is detected in invasive breast cancer cells and aggressive breast tumor malignancies. Here, we demonstrate that a major cause of high c-Jun abundance in invasive breast cancer cells is prolonged c-Jun protein stability owing to poor poly-ubiquitination of c-Jun. Among the known c-Jun-targeting E3 ligases, we identified constitutive photomorphogenesis protein 1 (COP1) as an E3 ligase responsible for c-Jun degradation in less invasive breast cancer cells because depletion of COP1 reduced c-Jun poly-ubiquitination leading to the stabilization of c-Jun protein. In a panel of breast cancer cell lines, we observed an inverse association between the levels of COP1 and c-Jun. However, overexpressing COP1 alone was unable to decrease c-Jun level in invasive breast cancer cells, indicating that efficient c-Jun protein degradation necessitates an additional event. Indeed, we found that glycogen synthase kinase 3 (GSK3) inhibitors elevated c-Jun abundance in less invasive breast cancer cells and that GSK3β nonphosphorylable c-Jun-T239A mutant displayed greater protein stability and poorer poly-ubiquitination compared to the wild-type c-Jun. The ability of simultaneously enforced expression of COP1 and constitutively active GSK3β to decrease c-Jun abundance in invasive breast cancer cells allowed us to conclude that c-Jun is negatively regulated through the coordinated action of COP1 and GSK3β. Importantly, co-expressing COP1 and active GSK3β blocked in vitro cell growth/migration and in vivo metastasis of invasive breast cancer cells. Gene expression profiling of breast tumor specimens further revealed that higher COP1 expression correlated with better recurrence-free survival. Our study supports the notion that COP1 is a suppressor of breast cancer progression.

Original languageEnglish (US)
Pages (from-to)1075-1085
Number of pages11
JournalNeoplasia (United States)
Volume15
Issue number9
DOIs
StatePublished - Sep 2013

ASJC Scopus subject areas

  • Cancer Research

Fingerprint Dive into the research topics of 'COP1 and GSK3β cooperate to promote c-Jun degradation and inhibit breast cancer cell tumorigenesis'. Together they form a unique fingerprint.

  • Cite this